Neuronetics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuronetics, Inc. on February 15, 2019, covering events that occurred on February 13, 2019. The filing addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Paulina Hill retired from the Board of Directors and the Audit Committee effective February 13, 2019. The filing states her retirement is not due to any disagreement with the Company.
- Appointment: Cheryl R. Blanchard was appointed to the Board to fill the vacancy created by Dr. Hill's resignation. She is considered an independent director and was appointed to the Compensation Committee.
- Committee Transition: Ron Hunt transitioned from the Compensation Committee to the Audit Committee.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No risks, contingencies, or unusual items were disclosed in this report. Dr. Blanchard's term will expire at the 2019 annual meeting of stockholders.
Key Facts for Investor Verification
- Confirm the effective date of the Board composition changes (February 13, 2019).
- Verify the independence status of the newly appointed director, Cheryl R. Blanchard.
- Note that the resignation of Paulina Hill was voluntary and not related to any disagreement with the Company.
- Review the attached press release (Exhibit 99.1) for additional public statements regarding these changes.